Phase II trial of Trastuzumab + CPT-11 therapy for HER2-positive advanced gastric cancer patients with prior chemotherapy
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2016
At a glance
- Drugs Irinotecan (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms HERBIS-5
- 07 Aug 2016 Status changed from active, no longer recruiting to completed, according to results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
- 05 Aug 2013 Actual initiation date changed from Aug 2012 to 12 Oct 2012 as reported by University Hospital Medical Information Network - Japan record.
- 13 Aug 2012 New trial record